Respiratory muscle strength during and after hospitalization for COPD exacerbation

Respiratory Care

Volumn 58, Issue 12, 2013, Pages 2142-2149

  Mesquita, Rafael ^a,b   Donária, Leila ^a   Genz, Isabel C H ^a   Pitta, Fabio ^a   Probst, Vanessa S ^a,b  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSIDADE NORTE DO PARANÁ   (Brazil)

Author keywords

COPD; Exacerbation; Hospitalization; Respiratory muscle strength; Respiratory muscles

Indexed keywords

FENOTEROL; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; TERBUTALINE; TIOTROPIUM BROMIDE;

AGED; ARTICLE; BREATHING EXERCISE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; EXPIRATORY MUSCLE STRENGTH; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INSPIRATORY CAPACITY; INSPIRATORY MUSCLE DYSFUNCTION; INSPIRATORY MUSCLE STRENGTH; LUNG FUNCTION; MALE; MUSCLE STRENGTH; MUSCLE WEAKNESS; OBSERVATIONAL STUDY; PERIPHERAL MUSCLE STRENGTH; PHYSIOTHERAPY; QUADRICEPS FEMORIS MUSCLE;

COPD; EXACERBATION; HOSPITALIZATION; RESPIRATORY MUSCLE STRENGTH; RESPIRATORY MUSCLES;

AGED; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; INSPIRATORY CAPACITY; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MUSCLE STRENGTH; PATIENT OUTCOME ASSESSMENT; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUSCLES; SEVERITY OF ILLNESS INDEX;

EID: 84888093053     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02393     Document Type: Article

References (29)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD (GOLD), revised 2011. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf. Accessed September 20, 2013.
2. Soler-Cataluna JJ, Martinez-Garcia MA, Roman SP, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60(11):925-931.
3. Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004;59(5):387-395.
4. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57(10): 847-852.
5. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest 2006;129(3):536-544.
6. Spruit MA, Gosselink R, Troosters T, Kasran A, Gayan-Ramirez G, Bogaerts P, et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003;58(9):752-756.
7. Vilaró J, Ramirez-Sarmiento A, Martinez-Llorens JM, Mendoza T, Alvarez M, Sanchez-Cayado N, et al. Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. Respir Med 2010;104(12):1896-1902.
8. Guerri R, Gayete A, Balcells E, Ramirez-Sarmiento A, Vollmer I, Garcia-Aymerich J, et al. Mass of intercostal muscles associates with risk of multiple exacerbations in COPD. Respir Med 2010;104(3): 378-388.
9. Gonzalez C, Servera E, Ferris G, Blasco ML, Marin J. Risk factors of readmission in acute exacerbation of moderate-to-severe chronic obstructive pulmonary disease. Arch Bronconeumol 2004;40(11): 502-507.
10. Gonzalez C, Servera E, Marin J. Importance of noninvasively measured respiratory muscle overload among the causes of hospital readmission of COPD patients. Chest 2008;133(4):941-947.
11. Marti{dotless}́nez-Llorens JM, Orozco-Levi M, Masdeu MJ, Coronell C, Ramirez-Sarmiento A, Sanjuas C, et al. Global muscle dysfunction and exacerbation of COPD: a cohort study. Med Clin (Barc) 2004; 122(14):521-527.
12. González C, Servera E, Celli B, Diaz J, Marin J. A simple noninvasive pressure-time index at the mouth to measure respiratory load during acute exacerbation of COPD: a comparison with normal volunteers. Respir Med 2003;97(4):415-420.
13. Laghi F, Tobin MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med 2003;168(1):10-48.
14. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117(5 Suppl 2):398S-401S.
15. American Thoracic Society; European Respiratory Society. ATS/ ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002;166(4):518-624.
16. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969;99(5): 696-702.
17. Windisch W, Hennings E, Sorichter S, Hamm H, Criee CP. Peak or plateau maximal inspiratory mouth pressure: which is best? Eur Respir J 2004;23(5):708-713.
18. Troosters T, Probst VS, Crul T, Pitta F, Gayan-Ramirez G, Decramer M, et al. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181(10): 1072-1077.
19. Probst VS, Troosters T, Heuzel K, van Bael J, Decramer M, Gosselink R. Comparison of two devices for measuring quadriceps force in COPD patients (abstract). Eur Respir J 2004;24(Suppl 48):666S.
20. Decramer M, Lacquet LM, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994;150(1):11-16.
21. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26(2):319-338.
22. Pereira CA, Sato T, Rodrigues SC. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 2007;33(4):397-406.
23. Neder JA, Andreoni S, Castelo-Filho A, Nery LE. Reference values for lung function tests. I. Static volumes. Braz J Med Biol Res 1999;32(6):703-717.
24. Kovelis D, Segretti NO, Probst VS, Lareau SC, Brunetto AF, Pitta F. Validation of the modified pulmonary functional status and dyspnea questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol 2008;34(12):1008-1018.
25. Tantucci C, Donati P, Nicosia F, Bertella E, Redolfi S, De VM, et al. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease. Respir Med 2008;102(4):613-619.
26. O'Donnell DE, Parker CM. COPD exacerbations. 3: pathophysiology. Thorax 2006;61(4):354-361.
27. O'Donnell DE, Guenette JA, Maltais F, Webb KA. Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise. Chest 2012;141(3): 753-762.
28. Decramer M. Hyperinflation and respiratory muscle interaction. Eur Respir J 1997;10(4):934-941.
29. O'Donnell DE. Dynamic lung hyperinflation and its clinical implication in COPD. Rev Mal Respir 2008;25(10):1305-1318.